T1	Premise 39 151	A 22-year-old boy with hyposmia presents lack of development of secondary sexual characteristics and infertility
T2	Premise 153 188	Bilateral testicular volume of 4 mL
T3	Premise 190 305	Analytically, EST-I 1.2 U/L (vn 5-15); LH 0.6 U/L (vn 3-15); testosterone 100 ng/dL (vn 300-1200), prolactin normal
T4	Claim 362 380	GnRH infusion pump
T5	Claim 385 436	Monthly intramuscular administration of triptorelin
T6	Claim 441 495	Intramuscular administration of FSH and LH once a week
T7	Claim 500 528	Treatment with bromocriptine
T8	Claim 555 637	This is a Kallman syndrome (hypogonadotropic hypogonadism + olfactory disturbance)
T9	Claim 639 792	Triptorelin is a GnRH agonist, which by continuous action reduces FSH and LH, and is used in sex hormone-dependent cancers, as well as precocious puberty
T10	Claim 892 915	We stay between 1 and 3
R1	Attack Ent1:T9 Ent2:T5	
R2	Attack Ent1:T1 Ent2:T9	
T11	Claim 794 891	Bromocriptine is a dopaminergic agonist used in hyperPRL (he has normal PRL), pituitary tumors...
R3	Attack Ent1:T3 Ent2:T11	
T12	Premise 852 869	he has normal PRL
R4	Attack Ent1:T12 Ent2:T11	
R5	Attack Ent1:T3 Ent2:T9	
R6	Attack Ent1:T11 Ent2:T7	
T13	Claim 917 1002	To induce testicular maturation, pulsatile GnRH with pump, hCG or FSH+hCG can be used
R7	Support Ent1:T13 Ent2:T4	
T14	Treatment 950 974	pulsatile GnRH with pump
T15	Treatment 976 979	hCG
T16	Treatment 983 990	FSH+hCG
T17	Claim 1004 1078	LH is not used as a treatment, it would be stimulated by intermittent GnRH
R8	Attack Ent1:T17 Ent2:T6	
T18	Treatment 1074 1078	GnRH
T19	Treatment 1004 1006	LH
T20	Disease 565 637	Kallman syndrome (hypogonadotropic hypogonadism + olfactory disturbance)
T21	Treatment 362 380	GnRH infusion pump
T22	Treatment 385 436	Monthly intramuscular administration of triptorelin
T23	Treatment 441 495	Intramuscular administration of FSH and LH once a week
T24	Treatment 500 528	Treatment with bromocriptine
